{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"23"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"23"}],"units":"Participants"}],"groups":[{"description":"Fludarabine 30 mg/m\\^2 intravenous (IV) daily over 30 minutes for 4 Days (Beginning Day -4).\n\nMelphalan 140 mg/m\\^2 IV over 20 minutes on Day -1. Stem Cell Infusion on Day 0. Rituximab 375 mg/m\\^2 IV infused starting on day -5.","id":"OG000","title":"Fludarabine + Melphalan + Stem Cell Infusion"},{"description":"Fludarabine 30 mg/m\\^2 IV daily over 30 minutes for 4 Days (Beginning Day -4).\n\nLower-Dose Melphalan 100 mg/m\\^2 IV over 20 minutes on Day -1. Stem Cell Infusion on Day 0. Rituximab 375 mg/m\\^2 IV infused starting on day -5.","id":"OG001","title":"Fludarabine + Lower-Dose Melphalan + Stem Cell Infusion"}],"paramType":"NUMBER","timeFrame":"Day 100","title":"Number of Participants With Successful Engraftment at Day 100","type":"PRIMARY","unitOfMeasure":"participants"}